Latest filing published 08 Aug 2024 for 宏源药业, €169k.
Filing timeline
BuySaleInsider track record
雷高良: trading record in brief
雷高良 is a declared insider of 宏源药业, with filings sourced from SSE / SZSE (CSRC). We count 4 filings; the first trade dates from 1 August 2024 and the latest from 8 August 2024.
Every open-market trade on record is a sale: 4 sales worth €842k.
The newest entry dates from 8 August 2024: an open-market sale of €169k, in 宏源药业. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 雷高良
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares20.1% of flowA股XSHESZSE:173000007935444930
- 100,000 shares20.0% of flowA股XSHESZSE:173000007925804130
- 174,000 shares35.0% of flowA股XSHESZSE:173000007917512350
- 126,000 shares24.9% of flowA股XSHESZSE:173000007910362850
4 of 4 declarations